These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 6681967)
1. Effects of oxametacin on coumarin anticoagulation and on platelet function in humans. Baele G; Rasquin K; Barbier F Arzneimittelforschung; 1983; 33(1):149-52. PubMed ID: 6681967 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of acetylsalicylic acid on human platelet function in normal volunteers and in women using a combined oral contraceptive regime. Baele G; Thiery M; Vermeulen A; Barbier F Thromb Haemost; 1976 Dec; 36(3):623-7. PubMed ID: 1037156 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of oxametacin in healthy volunteers following multiple administration (author's transl)]. Dittrich P; Ferber H; Vergin H; Kukovetz WR Arzneimittelforschung; 1981; 31(3):518-23. PubMed ID: 7194676 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of human platelet function by parsalmide. Fantasia R; Colombi M; Della Volpe A; Pogliani EM Arzneimittelforschung; 1982; 32(10):1312-4. PubMed ID: 6897511 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]
6. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists. Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
8. [Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement]. Toyohira H; Nakamura K; Kariyazono H; Yamada K; Moriyama Y; Shimokawa S; Saigenji H; Taira A Kyobu Geka; 1995 Aug; 48(9):749-55. PubMed ID: 7564036 [TBL] [Abstract][Full Text] [Related]
9. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women. Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation of juvenile sheep and goats with heparin, warfarin, and clopidogrel. Connell JM; Khalapyan T; Al-Mondhiry HA; Wilson RP; Rosenberg G; Weiss WJ ASAIO J; 2007; 53(2):229-37. PubMed ID: 17413565 [TBL] [Abstract][Full Text] [Related]
11. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery. Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331 [TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation. Galliard-Grigioni KS; Reinhart WH Eur J Pharmacol; 2009 May; 609(1-3):96-9. PubMed ID: 19272375 [TBL] [Abstract][Full Text] [Related]
13. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood. Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin. Storey RF; May JA; Heptinstall S Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100). Feuring M; Haseroth K; Janson CP; Falkenstein E; Schmidt BM; Wehling M Int J Clin Pharmacol Ther; 1999 Dec; 37(12):584-8. PubMed ID: 10599950 [TBL] [Abstract][Full Text] [Related]
16. Flavocoxid, an anti-inflammatory agent of botanical origin, does not affect coagulation or interact with anticoagulation therapies. Pillai L; Levy RM; Yimam M; Zhao Y; Jia Q; Burnett BP Adv Ther; 2010 Jun; 27(6):400-11. PubMed ID: 20556559 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related]
18. [Controlled, double blind study of a possible interaction between acemetacin and a concomitant anticoagulant therapy]. Hess H; Koeppen R Arzneimittelforschung; 1980; 30(8A):1421-3. PubMed ID: 7191309 [TBL] [Abstract][Full Text] [Related]
19. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110 [TBL] [Abstract][Full Text] [Related]